[Prognostic markers for prostate cancer]
Standard
[Prognostic markers for prostate cancer]. / Graefen, M; Hammerer, P; Noldus, J; Haese, Alexander; Pichelmeier, U; Erbersdobler, A; Henke, H; Conrad, S; Fernandez, S; Huland, H.
in: UROLOGE, Jahrgang 39, Nr. 1, 1, 2000, S. 14-21.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - [Prognostic markers for prostate cancer]
AU - Graefen, M
AU - Hammerer, P
AU - Noldus, J
AU - Haese, Alexander
AU - Pichelmeier, U
AU - Erbersdobler, A
AU - Henke, H
AU - Conrad, S
AU - Fernandez, S
AU - Huland, H
PY - 2000
Y1 - 2000
N2 - Careful consideration of therapy for prostate cancer needs an accurate analysis of prognostic markers to estimate success and benefit for the patient. Prognosis of prostate cancer is determined by the proportion of high grade cancer, many usually utilized prognostic characteristics were rejected by multivariate analysis as no independent prognostic information was delivered. For planning therapy it is crucial to estimate the proportion of high grade cancer as exact as possible. A standardized biopsy technique combined with a quantified analysis of the biopsy cores is most helpful to achieve this goal. The prognostic value of molecular biological and other factors is object of research, only a combination of some of these factors could be demonstrated so far to be superior to the estimation of the proportion of high grade cancer. However, at present their routine use in daily practise is precluded by a high technical and financial expense.
AB - Careful consideration of therapy for prostate cancer needs an accurate analysis of prognostic markers to estimate success and benefit for the patient. Prognosis of prostate cancer is determined by the proportion of high grade cancer, many usually utilized prognostic characteristics were rejected by multivariate analysis as no independent prognostic information was delivered. For planning therapy it is crucial to estimate the proportion of high grade cancer as exact as possible. A standardized biopsy technique combined with a quantified analysis of the biopsy cores is most helpful to achieve this goal. The prognostic value of molecular biological and other factors is object of research, only a combination of some of these factors could be demonstrated so far to be superior to the estimation of the proportion of high grade cancer. However, at present their routine use in daily practise is precluded by a high technical and financial expense.
M3 - SCORING: Zeitschriftenaufsatz
VL - 39
SP - 14
EP - 21
JO - UROLOGE
JF - UROLOGE
SN - 0340-2592
IS - 1
M1 - 1
ER -